Is Niagen Bioscience Inc halal to invest in?

As of July 2026, Niagen Bioscience Inc OCD1.BE is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Niagen Bioscience Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Niagen Bioscience Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Niagen Bioscience Inc?

Muslim investors may consider investing in Niagen Bioscience Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Niagen Bioscience Inc classified as HALAL?

Musaffa determines the Shariah status of Niagen Bioscience Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Niagen Bioscience Inc updated?

The Shariah compliance status of Niagen Bioscience Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Niagen Bioscience Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Niagen Bioscience Inc?

You can check the latest Shariah compliance status of Niagen Bioscience Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Niagen Bioscience Inc OCD1.BE

Last Updated: Dec 17, 12:00 AM·BE

OCD1.BE Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Niagen Bioscience Inc is classified as halal.

HALAL

Report Source: 2026 1st Quarter Report

Niagen Bioscience Inc. Stock Analysis OCD1.BE

Germany Health Care Small Cap Report: Q1, 2026

Niagen Bioscience, Inc. is a global bioscience company, which engages in acquiring, developing, and commercializing proprietary-based ingredient technologies. The company is headquartered in Los Angeles, California and currently employs 104 full-time employees. The company went IPO on 2007-06-25. The company is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. The Company’s Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients directly to consumers and distributors and offers NAD+ test kits exclusively to healthcare practitioners. The Ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and United States FDA-registered 503B outsourcing facilities, respectively. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.

Key Statistics of Niagen Bioscience Inc (OCD1.BE)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€5.60€5.65

Today's Open

€5.40

Volume

P/E Ratio (TTM)

15.56

Financial Metrics & Statements of Niagen Bioscience Inc (OCD1.BE)

Super Investors Invested in Niagen Bioscience Inc (OCD1.BE)

FAQ's for Niagen Bioscience Inc (OCD1.BE)

As of July 2026, Niagen Bioscience Inc OCD1.BE is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Niagen Bioscience Inc using these criteria to determine its compliance status.
Muslim investors may consider investing in Niagen Bioscience Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Niagen Bioscience Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Niagen Bioscience Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Niagen Bioscience Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.